Find research datasets worth reusing

Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)

ClinicalTrials.gov study NCT04554966. IPD Sharing: NO. Countries: 2. Publications: 0.

Movement Sonification as an add-on to Immediate Post-event Psychotherapeutic Intervention in the Management of Acute Stress Disorder: a Feasibility and Acceptability Study

ClinicalTrials.gov study NCT07307937. IPD Sharing: NO. Countries: 1. Publications: 0.

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR

ClinicalTrials.gov study NCT07155187. IPD Sharing: YES. Countries: 6. Publications: 0.

ORACLE-NIRS: Lipid cORe Plaque Association With CLinical Events: a Near-InfraRed Spectroscopy Study

ClinicalTrials.gov study NCT02265146. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

ClinicalTrials.gov study NCT07160179. IPD Sharing: NO. Countries: 1. Publications: 0.

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy

ClinicalTrials.gov study NCT00237146. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participant

ClinicalTrials.gov study NCT06896916. IPD Sharing: YES. Countries: 7. Publications: 0.

A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

ClinicalTrials.gov study NCT07185776. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.

A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death

ClinicalTrials.gov study NCT03619980. IPD Sharing: NO. Countries: 1. Publications: 0.

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

ClinicalTrials.gov study NCT06223516. IPD Sharing: NO. Countries: 4. Publications: 0.

Understanding and Anticipating Therapeutic Response And Immuno-meDIated Adverse Events in Anti-cancer Immune-checkpoint Inhibition: a Tissue Biopsy Based imaGing Study

ClinicalTrials.gov study NCT05921123. IPD Sharing: Not stated. Countries: 1. Publications: 0.

A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds

ClinicalTrials.gov study NCT06018987. IPD Sharing: YES. Countries: 1. Publications: 0.

A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

ClinicalTrials.gov study NCT06063967. IPD Sharing: YES. Countries: 20. Publications: 0.

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizuma

ClinicalTrials.gov study NCT06100744. IPD Sharing: YES. Countries: 9. Publications: 0.

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Blee

ClinicalTrials.gov study NCT02319460. IPD Sharing: Not stated. Countries: 1. Publications: 0.

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

ClinicalTrials.gov study NCT06696755. IPD Sharing: YES. Countries: 0. Publications: 0.

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

ClinicalTrials.gov study NCT07306832. IPD Sharing: NO. Countries: 0. Publications: 0.

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

ClinicalTrials.gov study NCT01829958. IPD Sharing: Not stated. Countries: 1. Publications: 0.

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgki

ClinicalTrials.gov study NCT05283720. IPD Sharing: YES. Countries: 13. Publications: 0.

Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese Participants

ClinicalTrials.gov study NCT07024797. IPD Sharing: NO. Countries: 1. Publications: 0.